Ligand validation:3VLJ

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 3VLJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VLJ_HEM_A_800	81%	5%	0.132	0.986	1.83	3.37	10	19	1	0	100%	1
3VLJ_HEM_B_800	78%	1%	0.138	0.98	1.95	5.9	12	27	2	0	100%	1
3VLI_HEM_A_800	83%	4%	0.123	0.982	1.96	3.57	14	24	3	0	100%	1
3VLH_HEM_A_800	78%	1%	0.132	0.976	1.89	5.75	11	29	2	0	100%	1
3VLL_HEM_B_800	78%	0%	0.121	0.964	2.41	9.61	12	33	0	0	100%	1
3VLK_HEM_A_800	77%	0%	0.134	0.974	2.09	6.93	14	29	1	0	100%	1
1ITK_HEM_A_800	76%	0%	0.139	0.977	2	7.82	12	32	0	0	100%	1
1FHF_HEM_A_350	100%	17%	0.021	0.997	1.8	1.82	12	3	4	0	100%	1
1HBH_HEM_B_148	100%	19%	0.016	0.998	1.59	1.89	8	11	2	0	100%	1
2D2C_HEM_A_301	100%	9%	0.024	0.999	2.2	2.28	9	12	4	0	100%	1
3EJD_HEM_B_405	100%	17%	0.018	0.998	1.9	1.69	6	8	2	0	100%	1
3EJE_HEM_B_405	100%	18%	0.022	0.997	1.91	1.6	8	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.